Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07322679 · ClinicalTrials.gov registry record · NA
Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults
A NA study, sponsored by Nanjing Nutrabuilding Bio-tech Co..
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07322679 is a NA study that has not yet begun recruiting, run by Nanjing Nutrabuilding Bio-tech Co.. The registered enrollment target is 120 participants.
The verdict
NCT07322679, a NA study, has not yet begun recruiting, sponsored by Nanjing Nutrabuilding Bio-tech Co..
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether dihydroberberine (DHB) supplementation can improve body composition, blood sugar control, energy levels, appetite, and mood in healthy adults with overweight or mild obesity. The study focuses on men and women aged 35-55 years with a BMI between 27.0 and 33.0 kg/m². The main questions it aims to answer are: Does daily DHB supplementation lead to greater reductions in body weight over 12 weeks compared to placebo? Does DHB improve glycemic responses, appetite regulation, energy levels, and mood, both acutely (short-term) and chronically (over 12 weeks)? Researchers will compare two groups-one receiving DHB (400 mg/day) and the other receiving a placebo-administered as two capsules twice daily for 12 weeks. Participants will: Attend three in-clinic visits over approximately 14 weeks (including screening, baseline, and week 12 visits) Undergo mixed-meal tolerance tests (MTTs) to assess glucose metabolism, appetite, and energy levels Complete body composition assessments (including DXA scans), blood tests (e.g., glucose, insulin, HbA1c), and mood questionnaires (POMS-2) Be monitored for safety throughout the study
Interventions
- DIETARY_SUPPLEMENT Placebo （Microcrystalline Cellulose）
- DIETARY_SUPPLEMENT Dihydroberberine（DHB）
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2026-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07322679
The ClinicalTrials.gov registry entry for NCT07322679 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nanjing Nutrabuilding Bio-tech Co., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo （Microcrystalline Cellulose） is the first listed.
NCT07322679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07322679 about?
NCT07322679 is a clinical study titled "Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults". The goal of this clinical trial is to evaluate whether dihydroberberine (DHB) supplementation can improve body composition, blood sugar control, energy levels, appetite, and mood in healthy adults with overweight or mild obesity. The study focuses on men and women aged 35-55 years with a BMI between...
What is the current status of trial NCT07322679?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-12-15. Estimated completion is 2026-09-25.
What interventions are being tested in trial NCT07322679?
The interventions under investigation include: Placebo （Microcrystalline Cellulose） (DIETARY_SUPPLEMENT), Dihydroberberine（DHB） (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07322679?
This trial is sponsored by Nanjing Nutrabuilding Bio-tech Co., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.